Effect of FMdC on the cell cycle of some leukemia cell lines

Cytometry

Volumn 37, Issue 4, 1999, Pages 302-307

  Skierski, Janusz S ^a   Koronkiewicz, Mirosława ^a   Grieb, Paweł ^b  

^a NATIONAL MEDICINES INSTITUTE   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

(E) 2' deoxy 2' (fluoromethylene) cytidine; Annexin V; Cell cycle; Cell death; Deoxycytidine; Flow cytometry; FMdC; HL 60 cells; L 1210 cells; MOLT 4 cells; Protein DNA content

Indexed keywords

DEOXYCYTIDINE KINASE; LIPOCORTIN 5; TEZACITABINE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CYCLE; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; DNA CONTENT; DRUG EFFECT; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONTENT;

EID: 0033485337     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19991201)37:4<302::AID-CYTO7>3.0.CO;2-7     Document Type: Article

References (24)

1. Bitonti AJ, Bush TL, Lewis MT, Sunkara PS. Response of human colon and prostate xenografts to (E)-2′-deoxy-2′-(fluoromethylene)cytidine, an inhibitor of ribonucleotide reductase. Anticancer Res 1995;15:179-182.
2. Bitonti A, Dumont JA, Bush TL, Cashman EA, Cross-Doersen DE, Wright PS, Matthews DP, McCarthy JR, Kaplan DA. Regression of human breast tumor xenografts in response to (E)-2′-deoxy-2′-(fluoromethylene)cytidine, an inhibitor of ribonucleoside diphosphate reductase. Cancer Res 1994;54:1485-1490.
3. Bridges CG, Ahmed SP, Sunkara PS, McCarthy JR, Tyms AS. The ribonucleotide reductase inhibitor (E)-2′(fluoromethylene)-2′-deoxy-cytidine (MDL 101,731): a potential topical therapy for herpes simplex virus infection. Antiviral Res 1995:27:325-334.
4. Bruno S, Ardelt B, Skierski JS, Traganos F, Darzynkiewicz Z. Different effects of staurosporine, an inhibitor of protein kinases, on the cell cycle and chromatin structure of normal and leukemic lymphocytes. Cancer Res 1992;52:470-473.
5. Darzynkiewicz Z, Traganos F. Multiparameter flow cytometry in studies of the cell cycle. In: Melamed M, Lindmo T, Mendelsohn ML, eds. Flow cytometry and sorting. New York: Wiley-Liss; 1990. p 469-501.
6. Darzynkiewicz Z, Buno S, Del Bino G, Gorczyca W, Hotz MA, Lassota P, Traganos F. Features of apoptotic cells measured by flow cytometry. Cytometry 1992;13:795-808.
7. Darzynkiewicz Z, Xun L, Gong J. Assays of cell viability: discrimination of cells dying by apoptosis. In: Darzynkiewicz Z, Robinson JP, Crissman HA, eds. Methods in cell biology. Vol. 41, part A. "Flow Cytometry". San Diego: Academic Press; 1994. p 15-38.
8. Darzynkiewicz Z, Juan G, Li X, Gorczyca W, Murakami T, Traganos F. Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis). Cytometry 1977;27:1-20.
9. Del Bino G, Skierski JS, Darzynkiewicz Z. Diverse effects of camptothecin, an inhibitor of topoisomerase I, on the cell cycle of lymphocytic (L1210, MOLT-4) and myelogenous (HL-60, KG1) leukemic cells. Cancer Res 1990;50:5746-5750.
10. Eriksson S, Kiedraszuk B, Munch-Petersen B, Oberg B, Johansson NG. Comparison of the substrate specificities of human thymidine kinase 1 and 2 and deoxycytidine kinase toward antiviral and cytostatic nucleoside analogs. Biochem Biophys Res Commun 1991;176:586-592.
11. Grieb P, Skierski J, Jagielski J, Ryba M, Mossakowski MJ. DNA protein flow cytometry of dissociated cultures of human anaplastic gliomas. Pattern of proliferation and differentiation, and the effect of a new cytostatic drug cladribine (2-CdA). Folia Neuropathol 1995;33:145-145
12. Hirota Y, Yoshioka A, Tanaka S, Watanabe K, Otani T, Minowada J, Matsuda A, Ueda T, Wataya Y. Imbalance of deoxyribonucleoside triphosphates, DNA double-strand breaks, and cell death caused by 2-chlorodeoxyadenosine. Cancer Res 1989;49:915-919.
13. Hotz MA, Gong J, Traganos F, Darzynkiewicz Z. Flow cytometric detection of apoptosis. Comparison of the assays of in situ DNA degradation and chromatin changes. Cytometry 1994;15:237-244.
14. Kanazawa J, Takahashi T, Gomi K, Okabe M. Antitumor activity of (E)-2′-deoxy-2′-(fluoromethylene)cytidine, an inhibitor of ribonucleotide reductase (abstract). Proc AACR 1995;36:A2416.
15. McCarthy JR, Matthews DP, Stemerick DM, Huber EW, Bey P, Lippert BJ, Snyder RD, Sunkara P. Stereospecific method to E and Z terminal fluoro olefins and its application to the synthesis of 2′-deoxy-2′-fluoromethylene nucleosides as potential inhibitors of ribonucleoside diphosphate reductase. J Am Chem Soc 1991;113:7439-7440.
16. Piepmeier JM, Rabidou N, Schold SC Jr, Bitonti AJ, Prakash NJ, Bush TL. In vitro and in vivo inhibition of glioblastoma and neuroblastoma with MDL101731, a novel ribonucleoside diphosphate reductase inhibitor. Cancer Res 1996;56:359-361.
17. Robertson LE, Chubb S, Meyn RE, Story M, Ford R, Hittelman WN, Plunkett W. Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2′-deoxyadenosine and 9-b-D-arabinosyl-2-fluoroadenine. Blood 1993;81:143-150.
18. Ross BD, Boklye K, Chenevert TL. Assessment of the growth and treatment of experimental intracranial gliomas using magnetic resonance imaging and spectroscopy. Sixth International Symposium on Pediatric Neuro-Oncology, Houston, TX, 1994, p 28.
19. Seto S, Carrera CJ, Kubota M, Wasson DB, Carson DA. Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes. J Clin Invest 1985;75:377-383.
20. Sun LQ, Li YX, Guillou L, Mirimanoff RO, Coucke PA. Antitumor and radiosensitizing effects of (E)-2′-deoxy-2′-(fluoromethylene) cytidine, a novel inhibitor of ribonucleoside diphosphate reductase, on human colon carcinoma xenografts in nude mice. Cancer Res 1997;57:4023-4028.
21. Takahashi T, Nakashima A, Kanazawa J, Yamaguchi K, Akinaga S, Tamaoki T, Okabe M. Metabolism and ribonucleotide reductase inhibition of (E)-2′-deoxy-2′-2′-(fluoromethylene)cytidine, MDL 101,731, in human cervical carcinoma HeLa S3 cells. Cancer Chemother Pharmacol 1998;41:268-274.
22. van Engeland M, Nieland LJW, Ramaekers FCS, Schutte B, Reutelingsperger CPM. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 1998;31:1-9.
23. Wright PS, Cross-Doersen D, Th'ng JPH, Guo XW, Crissman HA, Bradbury EM, Montgomery LR, Thompson FY, Loudy DE, Johnston JO, Bitonti AJ. A ribonucleoside reductase inhibitor, MDL 101,731, induces apoptosis and elevates TRPM-2 mRNA levels in human prostate tumor xenografts. Exp Cell Res 1996;222:54-60.
24. Zahorska R, Mazur L, Skierski JS, Grieb P. Antiviral activity of 2-Chloro-2′-Deoxyadenosine (2-CdA). Arch Immunol Ther Exp 1996; 44:137-141.